Phillips Geraint 4
4 · BIOLIFE SOLUTIONS INC · Filed Mar 12, 2024
Insider Transaction Report
Form 4
Phillips Geraint
SVP, Global Operations
Transactions
- Award
Common Stock
2024-03-08+11,682→ 69,802 total - Sale
Common Stock
2024-03-11$17.42/sh−206$3,589→ 69,596 total - Sale
Common Stock
2024-03-12$16.60/sh−3,598$59,727→ 65,998 total
Footnotes (2)
- [F1]The restricted stock was granted pursuant to the 2013 Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to 125% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2022 through December 31, 2023 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date).
- [F2]The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.